Marksans Pharma informs about ESG rating

27 Oct 2025 Evaluate
Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended, Marksans Pharma has informed that as per information received by the undersigned from BSE, CFC Finlease, a SEBI Licensed ESG Rating Provider (ERP), has voluntarily reviewed the ESG rating on the Company, based on data available in public domain for the Fiscal 2025, and assigned an ESG Score of ‘73’. The same can be accessed at https://www.bseindia.com/stock-share-price/marksans-pharmaltd/marksans/524404/intermediaries-ERP/.

The above information is a part of company’s filings submitted to BSE.  

Marksans Pharma Share Price

172.25 -0.20 (-0.12%)
16-Jan-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1669.20
Dr. Reddys Lab 1175.55
Cipla 1397.95
Zydus Lifesciences 867.80
Lupin 2176.25
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×